No association of initial GPRC5D expression on myeloma cells with GPRC5D-CARs expansion was observed; also, there was no significant difference in CARs expansion between patients treated with ATRA and those without exposure to ATRA. This evidence concerns the gene GPRC5D and plasma cell myeloma.